132 related articles for article (PubMed ID: 12767361)
1. Association between the clinical presentation and epidemiological features of familial prostate cancer in patients selected for radical prostatectomy.
Paiss T; Herkommer K; Bock B; Heinz H; Vogel W; Kron M; Kuefer R; Hautmann RE; Gschwend JE
Eur Urol; 2003 Jun; 43(6):615-21. PubMed ID: 12767361
[TBL] [Abstract][Full Text] [Related]
2. [Familial versus sporadic prostate cancer in the German population. Clinical and pathological characteristics in patients after radical prostatectomy].
Paiss T; Bock B; Gschwend JE; Heinz H; Vogel W; Kron M; Hautmann RE; Herkommer K
Urologe A; 2003 Jul; 42(7):946-53. PubMed ID: 12898039
[TBL] [Abstract][Full Text] [Related]
3. [Association of a positive family history with histopathology and clinical course in early-onset prostate cancer].
Herkommer K; Paiss T; Merz M; Gschwend JE; Kron M
Urologe A; 2006 Dec; 45(12):1532-9. PubMed ID: 17004091
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of patients with familial versus sporadic prostate cancer.
Roehl KA; Loeb S; Antenor JA; Corbin N; Catalona WJ
J Urol; 2006 Dec; 176(6 Pt 1):2438-42; discussion 2442. PubMed ID: 17085123
[TBL] [Abstract][Full Text] [Related]
5. Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.
Rouprêt M; Fromont G; Bitker MO; Gattegno B; Vallancien G; Cussenot O
Urology; 2006 May; 67(5):1028-32. PubMed ID: 16698363
[TBL] [Abstract][Full Text] [Related]
6. Familial prostate cancer: a different disease?
Kupelian PA; Klein EA; Witte JS; Kupelian VA; Suh JH
J Urol; 1997 Dec; 158(6):2197-201. PubMed ID: 9366343
[TBL] [Abstract][Full Text] [Related]
7. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.
Siddiqui SA; Sengupta S; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
J Urol; 2006 Sep; 176(3):1118-21. PubMed ID: 16890705
[TBL] [Abstract][Full Text] [Related]
8. Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases.
Azzouzi AR; Valeri A; Cormier L; Fournier G; Mangin P; Cussenot O
Urology; 2003 Jun; 61(6):1193-7. PubMed ID: 12809896
[TBL] [Abstract][Full Text] [Related]
9. The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited.
Cremers RG; Aben KK; van Oort IM; Sedelaar JP; Vasen HF; Vermeulen SH; Kiemeney LA
Prostate; 2016 Jul; 76(10):897-904. PubMed ID: 26989049
[TBL] [Abstract][Full Text] [Related]
10. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological features of hereditary prostate cancer.
Keetch DW; Humphrey PA; Smith DS; Stahl D; Catalona WJ
J Urol; 1996 Jun; 155(6):1841-3. PubMed ID: 8618269
[TBL] [Abstract][Full Text] [Related]
12. Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy.
Bauer JJ; Srivastava S; Connelly RR; Sesterhenn IA; Preston DM; McLeod DG; Moul JW
Urology; 1998 Jun; 51(6):970-6. PubMed ID: 9609635
[TBL] [Abstract][Full Text] [Related]
13. A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome.
Feneley MR; Gillatt DA; Hehir M; Kirby RS
Br J Urol; 1996 Dec; 78(6):911-8; discussion 919-20. PubMed ID: 9014719
[TBL] [Abstract][Full Text] [Related]
14. [Prospective evaluation of prostate cancer screening in men with a family history of the disease].
Paiss T; Herkommer K; Kahn D; Gschwend JE; Küfer R; Maier C; Vogel W; Högel J; Hautmann RE
Urologe A; 2006 Aug; 45(8):1002-5. PubMed ID: 16830128
[TBL] [Abstract][Full Text] [Related]
15. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
Moul JW; Connelly RR; Lubeck DP; Bauer JJ; Sun L; Flanders SC; Grossfeld GD; Carroll PR
J Urol; 2001 Oct; 166(4):1322-7. PubMed ID: 11547066
[TBL] [Abstract][Full Text] [Related]
16. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
Kupelian P; Katcher J; Levin H; Zippe C; Klein E
Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathological characteristics of familial prostate cancer in Finland.
Pakkanen S; Kujala PM; Ha N; Matikainen MP; Schleutker J; Tammela TL
BJU Int; 2012 Feb; 109(4):557-63. PubMed ID: 21507186
[TBL] [Abstract][Full Text] [Related]
18. Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.
Southwick PC; Catalona WJ; Partin AW; Slawin KM; Brawer MK; Flanigan RC; Patel A; Richie JP; Walsh PC; Scardino PT; Lange PH; Gasior GH; Parson RE; Loveland KG
J Urol; 1999 Oct; 162(4):1346-51. PubMed ID: 10492194
[TBL] [Abstract][Full Text] [Related]
19. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
20. The impact of a family history of prostate cancer on the prognosis and features of the disease in Korea: results from a cross-sectional longitudinal pilot study.
Lee KS; Koo KC; Chung BH
Int Urol Nephrol; 2017 Dec; 49(12):2119-2125. PubMed ID: 28905176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
